Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Karuna Therapeutics Inc (KRTX)

   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 77.711 - 78.225 78.225 - 78.691
Low: 73.912 - 74.566 74.566 - 75.157
Close: 76.082 - 77.12 77.12 - 78.058

Technical analysis

as of: 2020-09-25 4:32:00 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 94.46     One year: 102.62
Support: Support1: 69.58    Support2: 57.89
Resistance: Resistance1: 80.88    Resistance2: 87.86
Pivot: 79.10
Moving Average: MA(5): 77.90     MA(20): 77.86
MA(100): 88.47     MA(250): 75.21
MACD: MACD(12,26): -0.95     Signal(9): -1.03
Stochastic oscillator: %K(14,3): 37.80     %D(3): 43.90
RSI: RSI(14): 44.31
52-week: High: 152.00  Low: 11.24  Change(%): 372.4
Average Vol(K): 3-Month: 16864  10-Days: 22780

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
KRTX has closed above bottom band by 38.2%. Bollinger Bands are 2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 16 Sep 2020
Where Will Karuna Therapeutics Inc (KRTX) Stock Go Next After It Has Gained 16.93% in a Week? - InvestorsObserver

Mon, 14 Sep 2020
How Does Karuna Therapeutics Inc (KRTX) Stock Rank on Wall Street? - InvestorsObserver

Wed, 02 Sep 2020
New Strong Sell Stocks for September 2nd - Yahoo Finance

Tue, 01 Sep 2020
Karuna Therapeutics Becomes Oversold (KRTX) - Nasdaq

Wed, 05 Aug 2020
Karuna Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights - Business Wire

Sun, 28 Jun 2020
Hedge Funds Keep Buying Karuna Therapeutics, Inc. (KRTX) - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector: 
Industry: 
Shares Out. (M) 27
Shares Float (M) 18
% Held by Insiders 21.17
% Held by Institutions 63.53
Shares Short (K) 1,470
Shares Short P. Month (K) 1,680

Stock Financials

EPS -1.900
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 6.940
Profit Margin
Operating Margin
Return on Assets (ttm) -12.8
Return on Equity (ttm) -19.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.749
Qtrly Earnings Growth
Operating Cash Flow (M) -39
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio -40.58
PEG Ratio
Price to Book value 11.11
Price to Sales
Price to Cash Flow -52.13

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.